| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adjunctive Therapy With Brinzolamide 1% Ophthalmic Suspension (Azopt®) in Patients With Open-Angle Glaucoma or Ocular Hypertension Maintained on Timolol Therapy
|
Shin, Dong
|
|
2000
|
|
S2 |
p. S163-S168
6 p.
|
artikel
|
| 2 |
Analysis of animal models of macular edema
|
Bellhorn, Roy W.
|
|
1984
|
|
S2 |
p. 520-524
5 p.
|
artikel
|
| 3 |
Animal modeling of cystoid macular edema
|
Tso, Mark O.M.
|
|
1984
|
|
S2 |
p. 512-519
8 p.
|
artikel
|
| 4 |
Annotated bibliography
|
|
|
1984
|
|
S2 |
p. 577-619
43 p.
|
artikel
|
| 5 |
A perspective on the treatment of aphakic cystoid macular edema
|
Yannuzzi, Lawrence A.
|
|
1984
|
|
S2 |
p. 540-553
14 p.
|
artikel
|
| 6 |
Aphakic cystoid macular edema. Longterm clinical observations
|
Taylor, Daniel M.
|
|
1984
|
|
S2 |
p. 437-441
5 p.
|
artikel
|
| 7 |
Aphakic cystoid macular edema. The pharmacology of ocular trauma
|
Sears, Marvin L.
|
|
1984
|
|
S2 |
p. 525-534
10 p.
|
artikel
|
| 8 |
Breakdown of the blood-retinal barriers and cystoid macular edema
|
Cunha-Vaz, JoséG.
|
|
1984
|
|
S2 |
p. 485-492
8 p.
|
artikel
|
| 9 |
Changing Times for the Management of Diabetic Retinopathy
|
Fong, Donald S
|
|
2002
|
|
S2 |
p. S238-S245
8 p.
|
artikel
|
| 10 |
Circadian intraocular pressure management with Latanoprost: Diurnal and nocturnal intraocular pressure reduction and increased uveoscleral outflow
|
Mishima, Hiromu K.
|
|
1997
|
|
S2 |
p. S139-S144
6 p.
|
artikel
|
| 11 |
Clinical dose-regimen studies with latanoprost, a new ocular hypotensive PGF2α analogue
|
Diestelhorst, Michael
|
|
1997
|
|
S2 |
p. S77-S81
5 p.
|
artikel
|
| 12 |
Clinical evaluation of ketorolac tromethamine 0.5% ophthalmic solution for the treatment of seasonal allergic conjunctivitis
|
Ballas, Zuhair
|
|
1993
|
|
S2 |
p. 141-148
8 p.
|
artikel
|
| 13 |
Clinical evaluation of UF-021 (Rescula®; isopropyl unoprostone)
|
Yamamoto, Tetsuya
|
|
1997
|
|
S2 |
p. S99-S103
5 p.
|
artikel
|
| 14 |
Conjunctivitis of allergic origin: Clinical presentation and differential diagnosis
|
Friedlaender, Mitchell H.
|
|
1993
|
|
S2 |
p. 105-114
10 p.
|
artikel
|
| 15 |
Conjunctivitis of allergic origin: Immunologic mechanisms and current approaches to therapy
|
Abelson, Mark B.
|
|
1993
|
|
S2 |
p. 115-132
18 p.
|
artikel
|
| 16 |
Cyclooxygenase-2 inhibitors: A new approach to the therapy of ocular inflammation
|
Masferrer, Jaime L.
|
|
1997
|
|
S2 |
p. S35-S40
6 p.
|
artikel
|
| 17 |
Cystoid macular edema in pseudophakia
|
Stark Jr., Walter J.
|
|
1984
|
|
S2 |
p. 442-451
10 p.
|
artikel
|
| 18 |
Diabetic Retinopathy
|
Gardner, Thomas W
|
|
2002
|
|
S2 |
p. S253-S262
10 p.
|
artikel
|
| 19 |
Diagnosis of Dry Eye
|
Bron, Anthony J
|
|
2001
|
|
S2 |
p. S221-S226
6 p.
|
artikel
|
| 20 |
Differentiating conjunctivitis of diverse origins
|
Jackson, W.Bruce
|
|
1993
|
|
S2 |
p. 91-104
14 p.
|
artikel
|
| 21 |
Dose-Response Evaluation of the Ocular Hypotensive Effect of Brinzolamide Ophthalmic Suspension (Azopt®)
|
Silver, Lewis H.
|
|
2000
|
|
S2 |
p. S147-S153
7 p.
|
artikel
|
| 22 |
Double-masked, paired-comparison clinical study of ketorolac tromethamine 0.5% ophthalmic solution compared with placebo eyedrops in the treatment of seasonal allergic conjunctivitis
|
Tinkelman, David G.
|
|
1993
|
|
S2 |
p. 133-140
8 p.
|
artikel
|
| 23 |
Dry Eye Disease
|
Brewitt, Horst
|
|
2001
|
|
S2 |
p. S199-S202
4 p.
|
artikel
|
| 24 |
Effects of exogenous prostaglandins on aqueous humor dynamics and blood-aqueous barrier function
|
Toris, Carol B.
|
|
1997
|
|
S2 |
p. S69-S75
7 p.
|
artikel
|
| 25 |
Fluorescein angiographic evaluation of the effect of latanoprost treatment on blood-retinal barrier integrity: A review of studies conducted on pseudophakic glaucoma patients and on phakic and aphakic monkeys
|
Hoyng, Philip F.J.
|
|
1997
|
|
S2 |
p. S83-S88
6 p.
|
artikel
|
| 26 |
Foreword
|
Ferris III, Frederick L.
|
|
2002
|
|
S2 |
p. S237-
1 p.
|
artikel
|
| 27 |
Foreword
|
Henkind, Paul
|
|
1984
|
|
S2 |
p. 431-432
2 p.
|
artikel
|
| 28 |
Foreword: Diagnosing and managing allergic conjunctivitis
|
Friedlaender, Mitchell H.
|
|
1993
|
|
S2 |
p. 89-
1 p.
|
artikel
|
| 29 |
Increased Optic Nerve Head Blood Flow After 1 Week of Twice Daily Topical Brinzolamide Treatment in Dutch-Belted Rabbits
|
Barnes, George E
|
|
2000
|
|
S2 |
p. S131-S140
10 p.
|
artikel
|
| 30 |
Indomethacin in the treatment of postoperative cystoid macular edema
|
Miyake, Kensaku
|
|
1984
|
|
S2 |
p. 554-568
15 p.
|
artikel
|
| 31 |
Initial clinical studies with prostaglandins and their analogues
|
Camras, Carl B.
|
|
1997
|
|
S2 |
p. S61-S68
8 p.
|
artikel
|
| 32 |
Introduction
|
Bron, Anthony J.
|
|
2001
|
|
S2 |
p. S197-
1 p.
|
artikel
|
| 33 |
Introduction
|
Robin, Alan L
|
|
2000
|
|
S2 |
p. S117-S118
2 p.
|
artikel
|
| 34 |
Macular edema. A complication of diabetic retinopathy
|
Ferris III, Frederick L.
|
|
1984
|
|
S2 |
p. 452-461
10 p.
|
artikel
|
| 35 |
Macular edema secondary to occulusion of the retinal veins
|
Gutman, F.A.
|
|
1984
|
|
S2 |
p. 462-470
9 p.
|
artikel
|
| 36 |
Mechanisms for Monitoring Changes in Retinal Status Following Therapeutic Intervention in Diabetic Retinopathy
|
Lund-Andersen, Henrik
|
|
2002
|
|
S2 |
p. S270-S277
8 p.
|
artikel
|
| 37 |
Natural course of nonaphakic cystoid macular edema
|
Coscas, Gabriel
|
|
1984
|
|
S2 |
p. 471-484
14 p.
|
artikel
|
| 38 |
Ocular Comfort of Brinzolamide 1.0% Ophthalmic Suspension Compared With Dorzolamide 2.0% Ophthalmic Solution
|
Silver, Lewis H
|
|
2000
|
|
S2 |
p. S141-S145
5 p.
|
artikel
|
| 39 |
Pathogenesis of cystoid macular edema: An anatomic consideration of vitreoretinal adhesions
|
Sebag, J.
|
|
1984
|
|
S2 |
p. 493-498
6 p.
|
artikel
|
| 40 |
Pathology of human cystoid macular edema
|
Yanoff, Myron
|
|
1984
|
|
S2 |
p. 505-511
7 p.
|
artikel
|
| 41 |
Phase III latanoprost studies in Scandinavia, the United Kingdom and the United States
|
Alm, Albert
|
|
1997
|
|
S2 |
p. S105-S110
6 p.
|
artikel
|
| 42 |
Preclinical Overview of Brinzolamide
|
DeSantis, Louis
|
|
2000
|
|
S2 |
p. S119-S129
11 p.
|
artikel
|
| 43 |
Prevention of Visual Loss From Diabetic Retinopathy
|
Klein, Ronald
|
|
2002
|
|
S2 |
p. S246-S252
7 p.
|
artikel
|
| 44 |
Prophylaxis and therapy of aphakic cystoid macular edema
|
Jampol, Lee M.
|
|
1984
|
|
S2 |
p. 535-539
5 p.
|
artikel
|
| 45 |
Prostaglandin action on ciliary smooth muscle extracellular matrix metabolism: Implications for uveoscleral outflow
|
Lindsey, James D.
|
|
1997
|
|
S2 |
p. S53-S59
7 p.
|
artikel
|
| 46 |
Prostaglandin-induced iridial pigmentation in primates
|
Selén, Göran
|
|
1997
|
|
S2 |
p. S125-S128
4 p.
|
artikel
|
| 47 |
Prostaglandins: A new approach to glaucoma management with a new, intriguing side effect
|
Bito, Laszlo Z.
|
|
1997
|
|
S2 |
p. S1-S14
14 p.
|
artikel
|
| 48 |
Reduced intraocular pressure and increased ocular perfusion pressure in normal tension glaucoma: A review of short-term studies with three dose regimens of latanoprost treatment
|
Greve, Erik L.
|
|
1997
|
|
S2 |
p. S89-S92
4 p.
|
artikel
|
| 49 |
Retinal edema. Introduction to the First International Cystoid Macular Edema Symposium
|
Bird, A.C.
|
|
1984
|
|
S2 |
p. 433-436
4 p.
|
artikel
|
| 50 |
Role of the vitreous in cystoid macular edema
|
Schepens, Charles L.
|
|
1984
|
|
S2 |
p. 499-504
6 p.
|
artikel
|
| 51 |
Signal transduction and gene expression in the eye: A contemporary view of the pro-inflammatory, anti-inflammatory and modulatory roles of prostaglandins and other bioactive lipids
|
Bazan, Nicolas G.
|
|
1997
|
|
S2 |
p. S23-S34
12 p.
|
artikel
|
| 52 |
Structure-activity relationships and receptor profiles of some ocular hypotensive prostanoids
|
Resul, Bahram
|
|
1997
|
|
S2 |
p. S47-S52
6 p.
|
artikel
|
| 53 |
The additive intraocular pressure-lowering effect of latanoprost in combined therapy with other ocular hypotensive agents
|
Hoyng, Philip F.J.
|
|
1997
|
|
S2 |
p. S93-S98
6 p.
|
artikel
|
| 54 |
The color of the human eye: A review of morphologic correlates and of some conditions that affect iridial pigmentation
|
Imesch, Pascal D.
|
|
1997
|
|
S2 |
p. S117-S123
7 p.
|
artikel
|
| 55 |
The Efficacy and Safety of Brinzolamide 1% Ophthalmic Suspension (Azopt®) as a Primary Therapy in Patients With Open-Angle Glaucoma or Ocular Hypertension
|
Sall, Kenneth
|
|
2000
|
|
S2 |
p. S155-S162
8 p.
|
artikel
|
| 56 |
The incidence and time-course of latanoprost-induced iridial pigmentation as a function of eye color
|
Wistrand, Per J.
|
|
1997
|
|
S2 |
p. S129-S138
10 p.
|
artikel
|
| 57 |
The lack of respiratory effects of the ocular hypotensive drug latanoprost in patients with moderate-steroid treated asthma
|
Hedner, Jan
|
|
1997
|
|
S2 |
p. S111-S115
5 p.
|
artikel
|
| 58 |
The molecular biology and ocular distribution of prostanoid receptors
|
Woodward, D.E.
|
|
1997
|
|
S2 |
p. S15-S21
7 p.
|
artikel
|
| 59 |
The national, prospective, randomized vitrectomy study for chronic aphakic cystoid macular edema. Progress report and comparison between the control and nonrandomized groups
|
Fung, Wayne E.
|
|
1984
|
|
S2 |
p. 569-575
7 p.
|
artikel
|
| 60 |
The Ocular Surface and Tear Film and Their Dysfunction in Dry Eye Disease
|
Rolando, Maurizio
|
|
2001
|
|
S2 |
p. S203-S210
8 p.
|
artikel
|
| 61 |
The Pathology of Dry Eye
|
Baudouin, Christophe
|
|
2001
|
|
S2 |
p. S211-S220
10 p.
|
artikel
|
| 62 |
The Potential Role of PKC β in Diabetic Retinopathy and Macular Edema
|
Aiello, Lloyd Paul
|
|
2002
|
|
S2 |
p. S263-S269
7 p.
|
artikel
|
| 63 |
The prostaglandin transporter is widely expressed in ocular tissues
|
Schuster, Victor L.
|
|
1997
|
|
S2 |
p. S41-S45
5 p.
|
artikel
|
| 64 |
The Treatment of Dry Eye
|
Calonge, Margarita
|
|
2001
|
|
S2 |
p. S227-S239
13 p.
|
artikel
|
Tijdschrift beschrijving